1 (17.5%) |
12269726
|
Rippling muscle disease in childhood.
Schara U, Vorgerd M, Popovic N, Schoser BG, Ricker K, Mortier W.
J Child Neurol. 2002;17(7):483-90.
|
Muscle weakness
|
CAV3
|
rs116840778
|
Caveolin 3
Caveolins
Child
Child, Preschool
Creatine Kinase
Females
Homo sapiens
Infant
Male
Microscopy, Fluorescence
Mutation
Myopathy
Physical Stimulation
Western Blotting
|
1 (17.5%) |
11745958
|
Severe autosomal recessive rippling muscle disease.
Koul RL, Chand RP, Chacko A, Ali M, Brown KM, Bushnarmuth SR, Escolar DM, Stephan DA.
Muscle Nerve. 2001;24(11):1542-7.
|
Cardiomyopathy
Skeletal myopathy
|
|
|
Cardiac Arrhythmia
Electrocardiography
Fatal Outcome
Females
Genes, Recessive
Homo sapiens
Male
Myopathy
Phenotype
|
1 (17.5%) |
11353417
|
Rippling muscle disease: evidence for phenotypic and genetic heterogeneity.
So YT, Zu L, Barraza C, Figueroa KP, Pulst SM.
Muscle Nerve. 2001;24(3):340-4.
|
Myalgia
Muscle stiffness
|
|
rs116840778
|
Adult
Child
Chromosomes, Human, Pair 1
Females
Genetic Heterogeneity
Homo sapiens
Male
Middle Aged
Myopathy
Phenotype
|
1 (17.5%) |
10227634
|
Phenotypic variability in rippling muscle disease.
Vorgerd M, Bolz H, Patzold T, Kubisch C, Malin JP, Mortier W.
Neurology. 1999;52(7):1453-9.
|
Irritability
Muscle stiffness
|
|
rs116840778
rs116840789
rs121909278
|
Adult
Child
Child, Preschool
Chromosomes, Human, Pair 1
Females
Homo sapiens
Male
Middle Aged
Muscle Tissue
Myopathy
Phenotype
|
1 (17.5%) |
8574358
|
Intermittent esotropia associated with rippling muscle disease.
Kosmorsky GS, Mehta N, Mitsumoto H, Prayson R.
J Neuroophthalmol. 1995;15(3):147-51.
|
Esotropia
Myopathy
|
|
|
Biopsy
Diplopia
Electromyography
Esotropia
Homo sapiens
Male
Middle Aged
Myopathy
Myositis
Visual Acuity
|
1 (17.5%) |
2705900
|
Rippling muscle disease.
Ricker K, Moxley RT, Rohkamm R.
Arch Neurol. 1989;46(4):405-8.
|
Myopathy
|
|
rs116840773
rs116840805
|
Adult
Creatine Kinase
Electromyography
Heart Function Tests
Hematologic Tests
Homo sapiens
Isometric Contraction
Male
Middle Aged
Muscle Tissue
Myopathy
Thyroid Function Tests
|
17 (4.0%) |
26947586
|
Mutation in the caveolin-3 gene causes asymmetrical distal myopathy.
Chen J, Zeng W, Han C, Wu J, Zhang H, Tong X.
Neuropathology. 2016;36(5):485-489.
|
Cardiomyopathy
|
CAV3
|
c|SUB|G|136|A;RS#:116840789
p|SUB|A|46|T;RS#:116840789
rs116840789
|
Adult
Asians
Caveolin 3
Distal Muscular Dystrophies
Females
Heterozygote
Homo sapiens
Lower Extremity
Mutation
Phenotype
|
17 (4.0%) |
16688722
|
Sporadic rippling muscle disease unmasked by simvastatin.
Baker SK, Tarnopolsky MA.
Muscle Nerve. 2006;34(4):478-81.
|
Hypercholesterolemia
|
|
|
Anticholesteremic Agents
Caveolin 3
Dysferlin
Homeostasis
Homo sapiens
Hypercholesterolemia
Male
Membrane Proteins
Middle Aged
Muscle Contraction
Muscle Proteins
Myasthenia Gravis
Myopathy
|
17 (4.0%) |
16247063
|
Early-onset toe walking in rippling muscle disease due to a new caveolin-3 gene mutation.
Madrid RE, Kubisch C, Hays AP.
Neurology. 2005;65(8):1301-3.
|
Toe walking
|
|
c|SUB|G|136|A;RS#:116840789
rs116840793
|
Adult
Caveolae
Caveolin 3
Child
DNA Mutational Analysis
Exons
Gait Disorders, Neurologic
Genes, Dominant
Genetic Predisposition to Disease
Homo sapiens
Immunohistochemistry
Male
Mutation
Myopathy
Point Mutation
Skeletal Myocytes
Transmission Electron Microscopy
|
17 (4.0%) |
10619721
|
Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis.
Muller-Felber W, Ansevin CF, Ricker K, Muller-Jenssen A, Topfer M, Goebel HH, Pongratz DE.
Neuromuscul Disord. 1999;9(8):604-7.
|
Asthma
|
|
|
Adult
Homo sapiens
Immunosuppressive Agents
Male
Middle Aged
Muscle Contraction
Myasthenia Gravis
Myopathy
Physical Stimulation
|